Webinar Pre-Test: HIV Epidemiology, Guidelines, and Counseling (Part 1/3)

1. Pre-Test

Question Title

Please take a minute to complete this pre-session survey to help ARHP assess the impact of its educational programs. Completing this survey will provide ARHP with an invaluable tool for understanding how health professionals use educational offerings and how ARHP activities might be improved to serve you better.

Question Title

* Today's date (MM/DD/YYYY):

Question Title

* Your primary professional category (choose the one best response):

Health Professional Educator

Nurse Midwife

Nurse Practitioner

Pharmacist

Physician

Physician Assistant

Registered Nurse

Resident

Student

Other (please specify)

Question Title

* Do you interact with patients?

Yes

Question Title

* Which of the following populations is impacted by the highest prevalence of HIV infection?

A. Hispanic/Latino transgender man

B. African American cisgender man

C. African American transgender women

D. Hispanic/Latina cisgender woman

Question Title

* Which of the following reflects current CDC testing guidelines?

A. Everyone between the ages of 13 and 64 should be tested for HIV at least once, those with risk factors should be tested annually, and high-risk populations should be tested based on clinical determination.

B. People between the ages of 13 and 64 do not need to be tested for HIV unless they report having unprotected sex, those with risk factors should be tested every 3-6 months, and high-risk populations should be tested monthly.

C. Sexually active people between the ages of 13 and 64 should be tested annually for HIV, those with risk factors should be tested every 3-6 months, and high-risk populations should be tested monthly.

D. People between the ages of 13 and 64 do not need to be tested for HIV unless they report having unprotected sex, those with risk factors should be tested annually, and high-risk populations should be tested every 3-6 months.

Question Title

* Transgender women are __ times more at risk of HIV infection than other reproductive aged adults, with _% of infections occurring in Black/African American transgender women.

A. 4; 51

B. 14; 31

C. 24; 31

D. 34; 51

Question Title

* Which of the following strategies can be used to improve clinical care for cis and transgender women?

A. Utilize gender binaries to segregate sexual and reproductive health services by gender identity and sexuality

B. Aggregate HIV programming and research results for trans women and MSM

C. Use preferred names, pronouns, and gender-affirming terminology during counseling

D. Both A and B

Question Title

* As a result of participating in this activity, I hope to be better able to:

Thank you for completing this pre-session questionnaire.

Please follow these two steps to receive CE or CME credit for taking part in this activity.

1. Click here to view the archived webinar.

2. Click here after watching the webinar to complete the post-session survey

If you do not complete the post-webinar survey, you will not receive credit for this session. If you have any questions, please contact education@arhp.org.

Question Title

Question Title

* Today's date (MM/DD/YYYY):

Question Title

* Your primary professional category (choose the one best response):

Question Title

* Do you interact with patients?

Question Title

* Which of the following populations is impacted by the highest prevalence of HIV infection?

Question Title

* Which of the following reflects current CDC testing guidelines?

Question Title

* Transgender women are ____ times more at risk of HIV infection than other reproductive aged adults, with ___% of infections occurring in Black/African American transgender women.

Question Title

* Which of the following strategies can be used to improve clinical care for cis and transgender women?

Question Title

* As a result of participating in this activity, I hope to be better able to:

Question Title

* Transgender women are __ times more at risk of HIV infection than other reproductive aged adults, with _% of infections occurring in Black/African American transgender women.